We are live on
!
Find out more
Vanguard Fiduciary Trust Portfolio holdings
AUM
$454B
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$454B
AUM Growth
+$58.2B
(+15%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
29.47%
Holding
4,173
New
110
Increased
2,643
Reduced
1,032
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$644M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$393M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$170M |
| 5 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$401M |
| 2 |
Apple
AAPL
|
+$206M |
| 3 |
Microsoft
MSFT
|
+$175M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.13% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 10.07% |
| 4 | Healthcare | 9.55% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRML
3626
Greenland Mines Ltd
GRML
$30M
| $167K | ﹤0.01% |
641,720
+270,017
| +73% | +$100K |
|
3627
Lisata Therapeutics
LSTA
$9.73M
| $166K | ﹤0.01% |
48,964
+14,047
| +40% | +$50K |
|
3628
US GoldMining
USGO
$126M
| $166K | ﹤0.01% |
20,433
+6,689
| +49% | +$74.4K |
|
3629
John Wiley & Sons Class B
WLYB
| $165K | ﹤0.01% |
3,535
+31
| +0.9% | +$1.3K |
|
3630
Aligos Therapeutics
ALGS
$41.1M
| $165K | ﹤0.01% |
28,612
+175
| +0.6% | +$1.08K |
|
3631
PEDEVCO
PED
$167M
| $164K | ﹤0.01% |
12,221
+635
| +5% | +$9.24K |
|
3632
Protalix BioTherapeutics
PLX
$185M
| $164K | ﹤0.01% |
70,277
+6,926
| +11% | +$14.7K |
|
|
RTB
3633
RTB Digital
RTB
$230M
| $163K | ﹤0.01% |
10,837
+5,820
| +116% | +$37.8K |
|
|
BOLD
3634
Boundless Bio
BOLD
$64.4M
| $163K | ﹤0.01% |
65,136
| – | – |
|
|
IMA
3635
ImageneBio Inc
IMA
$63.3M
| $162K | ﹤0.01% |
27,475
+189
| +0.7% | +$1.07K |
|
3636
MIRA Pharmaceuticals
MIRA
$33.2M
| $162K | ﹤0.01% |
170,668
+1,185
| +0.7% | +$1.2K |
|
|
CNSY
3637
Cerenome
CNSY
$22M
| $161K | ﹤0.01% |
36,868
-9,683
| -21% | -$52.8K |
|
3638
TELA Bio
TELA
$29.2M
| $160K | ﹤0.01% |
213,138
+1,476
| +0.7% | +$1.21K |
|
3639
flyExclusive
FLYX
$117M
| $160K | ﹤0.01% |
79,805
+35,791
| +81% | +$83K |
|
3640
FerroAtlántica
GSM
$802M
| $159K | ﹤0.01% |
50,132
+4,217
| +9% | +$17.4K |
|
|
GRDX
3641
GridAI Technologies Corp
GRDX
$28M
| $159K | ﹤0.01% |
33,804
+17,459
| +107% | +$66.5K |
|
3642
Actinium Pharmaceuticals
ATNM
$32.9M
| $158K | ﹤0.01% |
161,526
+1,261
| +0.8% | +$1.46K |
|
|
FTH
3643
Faeth Therapeutics
FTH
$847M
| $158K | ﹤0.01% |
6,307
| – | – |
|
|
ROLR
3644
High Roller Technologies
ROLR
$62.7M
| $156K | ﹤0.01% |
26,376
+8,878
| +51% | +$56.9K |
|
|
SEV
3645
Aptera Motors
SEV
$88M
| $155K | ﹤0.01% |
63,357
+11,079
| +21% | +$28.4K |
|
3646
ABVC BioPharma
ABVC
$22.7M
| $154K | ﹤0.01% |
97,363
| – | – |
|
3647
PAVmed
PAVM
$38.2M
| $152K | ﹤0.01% |
25,605
+20,176
| +372% | +$143K |
|
3648
Xos
XOS
$29.7M
| $151K | ﹤0.01% |
50,085
+23,845
| +91% | +$58.3K |
|
3649
Civeo
CVEO
$349M
| $151K | ﹤0.01% |
+4,316
| New | +$139K |
|
3650
Milestone Scientific
MLSS
$43.3M
| $149K | ﹤0.01% |
464,449
+142,866
| +44% | +$49.1K |
|
Similar funds
Vanguard Fiduciary Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Fiduciary Trust held 4,173 positions worth $454B, up 15% from $396B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Fiduciary Trust opened 110 new positions and exited 97, leaving the 4,173-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- Vanguard Fiduciary Trust's largest Q2 2026 buy was SpaceX: 3,791,999 shares worth $648M.
- Vanguard Fiduciary Trust added most to Alphabet (Google) Class A in Q2 2026, an estimated $173M increase.
- Vanguard Fiduciary Trust's biggest Q2 2026 reduction was Honeywell, cutting an estimated $401M.
- Vanguard Fiduciary Trust fully exited Coterra Energy in Q2 2026, selling an estimated $149M.
- Vanguard Fiduciary Trust's ten largest holdings make up 29% of its $454B portfolio in Q2 2026.
- Vanguard Fiduciary Trust opened 110 new positions and closed 97 in Q2 2026.
- Vanguard Fiduciary Trust's portfolio value rose 15% quarter-over-quarter to $454B.
Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.